Preliminary Studies on the Expression and Purification of Functionally Active Recombinant Plasmepsin 9 from Plasmodium falciparum

References (24)

1. 1 A Rapid and Sensitive Method for the Quantitation of Microgram Quantities of Protein Utilizing the Principle of Protein-Dye Binding [DOI]
2. 2 Genome sequence of the human malaria parasite Plasmodium falciparum [DOI]
3. 3 The Transcriptome of the Intraerythrocytic Developmental Cycle of Plasmodium falciparum [DOI]
4. 4 A proteomic view of the Plasmodium falciparum life cycle [DOI]
5. 5 Discovery of Gene Function by Expression Profiling of the Malaria Parasite Life Cycle [DOI]
6. 6 Four plasmepsins are active in the Plasmodium falciparum food vacuole, including a protease with an active-site histidine [DOI]
7. 7 Aspartic proteases of Plasmodium falciparum and other parasitic protozoa as drug targets [DOI]
8. 8 Plasmepsin V licenses Plasmodium proteins for export into the host erythrocyte [DOI]
9. 9 Hemoglobin degradation in the human malaria pathogen Plasmodium falciparum: a catabolic pathway initiated by a specific aspartic protease. [DOI]
10. 10 Heterologous expression of proteins from Plasmodium falciparum: Results from 1000 genes [DOI]
11. 11 Novel Uncomplexed and Complexed Structures of Plasmepsin II, an Aspartic Protease from Plasmodium falciparum [DOI]
12. 12 Characterization of plasmepsin V, a membrane-bound aspartic protease homolog in the endoplasmic reticulum of Plasmodium falciparum [DOI]
13. 13 Heterologous expression of plasmodial proteins for structural studies and functional annotation [DOI]
14. 14 Role of Plasmodium falciparum Digestive Vacuole Plasmepsins in the Specificity and Antimalarial Mode of Action of Cysteine and Aspartic Protease Inhibitors [DOI]
15. 15 HIV and malaria co-infection: interactions and consequences of chemotherapy [DOI]
16. 16 Crystal structures of the free and inhibited forms of plasmepsin I (PMI) from Plasmodium falciparum [DOI]
17. 17 Expression and Characterisation of Plasmepsin I from Plasmodium falciparum [DOI]
18. 18 Activity and inhibition of plasmepsin IV, a new aspartic proteinase from the malaria parasite, Plasmodium falciparum [DOI]
19. 19 Achiral, Cheap, and Potent Inhibitors of Plasmepsins I, II, and IV [DOI]
20. 20 Naturally‐occurring and recombinant forms of the aspartic proteinases plasmepsins I and II from the human malaria parasite Plasmodium f alciparum [DOI]
21. 21 Active-Site Specificity of Digestive Aspartic Peptidases from the Four Species of Plasmodium that Infect Humans Using Chromogenic Combinatorial Peptide Libraries [DOI]
22. 22 Computational Perspectives into Plasmepsins Structure—Function Relationship: Implications to Inhibitors Design [DOI]
23. 23 Analysis of Proteinase Specificity by Studies of Peptide Substrates [DOI]
24. 24 Investigation of 2-Fold Disorder of Inhibitors and Relative Potency by Crystallizations of HIV-1 Protease in Ritonavir and Saquinavir Mixtures [DOI]

Cited by 0

No indexed citations yet.

Related research

• ABO Blood Groups and Malaria Prevalence in a Referral Hospital in Nigeria — shares topic coverage
• Prevalence of Malaria among Pregnant Women and Children Under Five Years in Abi Local Government Area, Cross River State, Nigeria — shares topic coverage
• A Study on Relationship of Thrombocytopenia and Likelihood of Severe Malaria in Patients Admitted With Malaria in a Tertiary Care Hospital of Dakshina Kannada — shares topic coverage
• Platelet Alteration in Plasmodium vivax Malaria Patients in Thailand — shares topic coverage
• Patients’ Perception of Health Care Services in Malaria Endemic Area in Mali: Villages with Health Care Services Versus villages Without Health Care Services — shares topic coverage